[Clinical experience in Hurthle cell tumors]

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Context:

• Hürthle cell tumors are a subtype of thyroid neoplasms.
• Distinguishing between benign Hürthle cell adenomas and malignant Hürthle cell carcinomas can be challenging.
• Surgical treatment is the primary modality for these tumors.

Purpose:

• To evaluate the surgical outcomes and prognostic factors in patients with Hürthle cell tumors.
• To investigate the utility of nuclear DNA content and ploidy analysis in differentiating Hürthle cell adenomas from carcinomas.
• To assess the recurrence and mortality rates following surgical intervention.

Summary:

• Ten patients with Hürthle cell tumors (6 carcinomas, 4 adenomas) underwent primary surgical treatment between 1987 and 1997.
• Diagnosis was based on >75% Hürthle cells, with malignancy defined by capsular/vascular invasion.
• All patients had a follow-up of 1-8 years (mean 4.5 years) with no reported deaths or recurrences.
• Nuclear DNA content analysis showed mixed results, with both euploid and aneuploid patterns observed in both adenomas and carcinomas.
• The study concluded that DNA content and ploidy are not yet reliable for distinguishing between benign and malignant Hürthle cell neoplasms or for prognosis due to limited patient numbers and follow-up.

Impact:

• Highlights the generally favorable surgical outcomes for Hürthle cell tumors.
• Suggests limitations of current DNA ploidy analysis in clinical decision-making for Hürthle cell neoplasms.
• Underscores the need for larger studies with longer follow-up to establish definitive prognostic markers.